We’re at the start of a revolution that will transform our lives as radically as the computer revolution of the 70s. The biological revolution will touch every aspect of our lives: food and health, certainly, but also art, recreation, law, business, and much more.
BioCoder is the newsletter of that revolution. It’s about biology as it moves from research labs into startup incubators, hacker spaces, and even homes. It’s about a very old programming language that we’re just beginning to understand, and that’s written in a code made up of organic chemicals. It’s the product of a sharing community of scientists that stretches from grade school to post docs and university faculty.
- Articles about interesting projects and experiments
- Articles about tools, both those you buy and those you build
- Visits to DIYbio laboratories
- Profiles of key people in the community
- Announcements of events and other items of interest
- Safety pointers and tips about good laboratory practice
- Anything that’s interesting or useful: you tell us!
If you’d like to contribute, send email to BioCoder@oreilly.com. Tell us what you’d like to do, and we’ll get you started.
Upcoming Bio-Related Events
SynBioBeta SF 2015 brings together some of the best minds from the worlds of biotechnology and synthetic biology. Discover what's happening in the industry and what's in store for the future with panel discussions from more than 80 industry speakers.
Tim O’Reilly of O’Reilly Media will be presenting the opening keynote “The Architecture of Participation: Open Source Lessons for Synthetic Biology,” which will then lead into a panel discussion with O’Reilly, Roger Chen (O’Reilly AlphaTech Ventures), Christine Gould (Syngenta), Jim Haseloff (OpenPlant, University of Cambridge), and Kiersten Stead (Monsanto Growth Ventures). Learn more.
“Biohackers are foot soldiers of the next revolution in biotechnology and medicine, willing to do what others can’t or won’t.” – Ryan Bethencourt, Contributor
“Biology in 2013 feels like computing in 1975 (just before the PC): ripe for an explosion.” – Mike Loukides, Editor
@NinaDiPrimio is a scientist at a startup focusing on high throughput therapeutic discovery for orphan diseases using model organisms. She earned her PhD in gene therapy, was teaching faculty for laboratory courses, and completed postdoctoral training in synthetic biology. When not at the bench she is thinking about viruses, how to make biology more accessible, and science education.
@mikeloukides is Vice President of Content Strategy for O’Reilly Media, Inc. He’s particularly interested in programming languages, Unix and what passes for Unix these days, and system and network administration. Most recently, he’s been fooling around with data and data analysis, languages like R, Mathematica, and Octave, and thinking about how to make books social.